CoreCivic (CXW) Earnings: Q3 2026 Results

The quarter ended September 30, 2026 and CoreCivic published the results on November 4, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. CoreCivic reports EPS two ways: GAAP, under the accounting rules every US filer follows, and Adjusted Diluted EPS, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Q3 2026 GAAP net income of $1,344.1 million and diluted EPS of $14.49 include a $1,770.7 million gain on the sale of four detention facilities to the federal government. Adjusted Diluted EPS excludes it.
• CoreCivic changed its reportable segments in Q2 2026, after buying Clinical Solutions Pharmacy, to CoreCivic Residential, CoreCivic Services and CoreCivic Properties. The year-ago segment figures are its recast ones from the 10-Q.
• Segment revenue is from CoreCivic's 10-Q; Services revenue is net of intercompany eliminations.

Source: CoreCivic Q3 2026 results, November 4, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How CoreCivic splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• CoreCivic's CoreCivic Residential revenue was $652 million in Q3 2026, up 15% from $566 million in Q3 2025, 88% of total revenue.
• CoreCivic's CoreCivic Services revenue was $87.5 million in Q3 2026, up 775% from $10.0 million in Q3 2025, 12% of total revenue.
• CoreCivic's CoreCivic Properties revenue was $4.7 million in Q3 2026, flat on $4.7 million in Q3 2025, under 1% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

CoreCivic prints its guidance as a table; each line above is copied from it.

In its Q3 2026 release, CoreCivic said:

“Adjusted Diluted EPS $1.74 to $1.80”

“Normalized FFO per diluted share $2.78 to $2.85”

“Adjusted EBITDA $442.5 million to $445.5 million”

“Our updated guidance does not include the impact of any potential additional facility sales.”

Source: CoreCivic Q3 2026 release, Nov 4, 2026.

This is the company's own guidance as of Nov 4, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the CXW forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

GAAP revenue and diluted EPS, each as first reported in that quarter's release. Q3 2026 EPS includes the gain on the four facility sales.

We do not hold a confirmed date for CoreCivic's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 4, 2026

CoreCivic's Q3 2026 revenue was $744.1 million, up 28.2% from $580.4 million. The CoreCivic Residential segment, the correctional, detention and reentry facilities it manages, produced $651.9 million. CoreCivic Services, which since April 1, 2026 includes the mail order pharmacy Clinical Solutions Pharmacy (CSP) along with TransCor transportation and Recovery Monitoring Solutions, produced $87.5 million, up from $10.0 million. CoreCivic Properties, five facilities leased to government agencies, produced $4.7 million. (CoreCivic Q3 2026 release, Nov 4, 2026; CoreCivic Form 10-Q, Q3 2026, Nov 5, 2026)

Residential revenue rose 15.2%. CoreCivic attributed $33.8 million of the increase to a 5.5% rise in average revenue per compensated man-day, to $117.40, from per diem increases and business mix, and $52.4 million to a 9.3% rise in average daily compensated population, to 60,352. Average compensated occupancy rose to 84.0% from 76.7%. (CoreCivic Form 10-Q, Q3 2026, Nov 5, 2026)

CoreCivic said the population increase came largely from higher ICE populations at reactivated facilities. Those at Dilley, California City, West Tennessee, Diamondback and the Midwest Facility added 4,775 to the average daily compensated population. CoreCivic expects the West Tennessee, California City, Diamondback and Midwest facilities to generate about $320.0 million of annual revenue once fully activated, and the Appleton Facility, under a new five-year ICE contract from August 11, 2026, about $75.0 million. (CoreCivic Q3 2026 release, Nov 4, 2026; CoreCivic Form 10-Q, Q3 2026, Nov 5, 2026)

Federal customers in the Residential segment, mainly ICE and the U.S. Marshals Service, generated 53% of CoreCivic's total revenue in Q3 2026, against 55% a year earlier, and their revenue rose $71.3 million, or 22.2%. For 2025 as a whole, ICE accounted for 35% of total revenue and the USMS for 18%. (CoreCivic Q3 2026 release, Nov 4, 2026; CoreCivic Form 10-K, 2025, Feb 20, 2026)

CoreCivic's GAAP diluted EPS of $14.49 in Q3 2026, against $0.24 a year earlier, came from selling four detention facilities with 7,187 beds to the federal government for $2.2 billion. The sales produced a $1,770.7 million gain on sale of real estate assets, net, and income tax expense rose to $505.3 million. CoreCivic keeps managing the facilities under its ICE contracts. (CoreCivic Q3 2026 release, Nov 4, 2026)

Adjusted Diluted EPS, which excludes the gain, a $22.1 million contingent consideration gain on the CSP acquisition, $4.0 million of debt repayment expenses, $6.4 million of executive transition settlement compensation and merger costs, net of tax, was $0.49, against $0.24. Normalized FFO per diluted share was $0.75, against $0.48. (CoreCivic Q3 2026 release, Nov 4, 2026)

Weighted average diluted shares fell 13.8% to 92.7 million from 107.5 million, mainly because of the $500.0 million accelerated share repurchase signed on August 10, 2026, under which CoreCivic received 12.4 million shares up front. CoreCivic also repaid over $700 million of debt, cutting total debt to $629.6 million at September 30, 2026, and interest expense, net fell to $7.0 million from $16.6 million. (CoreCivic Q3 2026 release, Nov 4, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

CoreCivic gives full-year guidance in its release. For 2026 it raised Adjusted Diluted EPS guidance to $1.74 to $1.80 from $1.64 to $1.73, Normalized FFO per diluted share to $2.78 to $2.85 and Adjusted EBITDA to $442.5 million to $445.5 million. GAAP diluted EPS guidance, which includes the facility sale gains, was $15.42 to $15.48, down from $15.62 to $15.82. (CoreCivic Q3 2026 release, Nov 4, 2026)

CoreCivic said its guidance includes its best estimate of how the change in ownership will affect the management contracts for the four sold facilities, which have not yet been modified, and excludes any further facility sales to ICE, which it described as in preliminary discussions. (CoreCivic Q3 2026 release, Nov 4, 2026)

A consensus figure is the average of the models published by the analysts who cover CoreCivic, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones CoreCivic's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning CXW is on is CXW a buy or a sell?, what analysts expect next is on the CXW forecast, and what the company does is on the CoreCivic (CXW) stock page.

Every number on this page can be traced to a document CoreCivic published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.